This article aims to characterize the differences in results from routine examinations between GCK‐MODY and hepatocyte nuclear factor 1‐α (HNF1A)‐MODY or type 2 diabetes (T2D) patients in different periods of diabetes. This evidence concerns the gene GCK and type 2 diabetes mellitus.